Clinical pharmacokinetics of salmeterol (Q34515200)

2 August 2017

1 reference

title

Clinical pharmacokinetics of salmeterol (English)

1 reference

2 August 2017

1 reference

Mario Cazzola

1

1 reference

2 August 2017

Renato Testi

series ordinal

2

1 reference

2 August 2017

Maria Gabriella Matera

series ordinal

3

1 reference

2 August 2017

1 January 2002

1 reference

Clinical Pharmacokinetics

2 August 2017

1 reference

2 August 2017

41

1 reference

2 August 2017

19-30

1 reference

2 August 2017

1

1 reference

https://scigraph.springernature.com/pub.10.2165/00003088-200241010-00003

2 August 2017

0 references

cites work

Time course and relative dose potency of systemic effects from salmeterol and salbutamol in healthy subjects

1 reference

12 December 2020

Pharmacokinetics of inhaled salbutamol in patients with cystic fibrosis versus healthy young adults

1 reference

12 December 2020

Salmeterol xinafoate. A review of its pharmacological properties and therapeutic potential in reversible obstructive airways disease

1 reference

12 December 2020

Clinical pharmacokinetics of beta-agonists

1 reference

12 December 2020

Inhaled salmeterol and salbutamol in asthmatic patients. An evaluation of asthma symptoms and the possible development of tachyphylaxis

1 reference

12 December 2020

Can lung deposition data act as a surrogate for the clinical response to inhaled asthma drugs?

1 reference

12 December 2020

Kinetic analysis of drug-receptor interactions of long-acting beta2 sympathomimetics in isolated receptor membranes: evidence against prolonged effects of salmeterol and formoterol on receptor-coupled adenylyl cyclase.

1 reference

12 December 2020

Disposition of salmeterol xinafoate in laboratory animals and humans

1 reference

12 December 2020

Salmeterol and fluticasone propionate given as a combination. Lack of systemic pharmacodynamic and pharmacokinetic interactions

1 reference

12 December 2020

Why are long-acting beta-adrenoceptor agonists long-acting?

1 reference

12 December 2020

Pharmacokinetic optimisation of asthma treatment

1 reference

12 December 2020

The aliphatic oxidation of salmeterol to alpha-hydroxysalmeterol in human liver microsomes is catalyzed by CYP3A.

1 reference

12 December 2020

The 1990 Lilly Prize Lecture. A way of looking at agonism and antagonism: lessons from salbutamol, salmeterol and other beta- adrenoceptor agonists

1 reference

12 December 2020

The determination in human plasma of 1-hydroxy-2-naphthoic acid following administration of salmeterol xinafoate

1 reference

12 December 2020

Safety and appropriate use of salmeterol in the treatment of asthma. AAAAI Committee on Drugs, American Academy of Allergy, Asthma and Immunology

1 reference

12 December 2020

Pharmacological basis for duration of effect: formoterol and salmeterol versus short-acting beta 2-adrenoceptor agonists.

1 reference

12 December 2020

Relaxation kinetics of formoterol and salmeterol in the guinea pig trachea in vitro

1 reference

12 December 2020

Pharmacodynamic and pharmacokinetic aspects on the transport of bronchodilator drugs through the tracheal epithelium of the guinea-pig

1 reference

12 December 2020

Difference in pulmonary absorption of inhaled terbutaline in healthy smokers and non-smokers

1 reference

12 December 2020

Dose-response study with high-dose inhaled salmeterol in healthy subjects

1 reference

12 December 2020

Salmeterol, a novel, long-acting β2-adrenoceptor agonist: characterization of pharmacological activity in vitro and in vivo

1 reference

12 December 2020

Salmeterol. A review of its pharmacological properties and clinical efficacy in the management of children with asthma

1 reference

12 December 2020

Exosites: their current status, and their relevance to the duration of action of long-acting beta 2-adrenoceptor agonists

1 reference

12 December 2020

Effect of inhaled formoterol and budesonide on exacerbations of asthma. Formoterol and Corticosteroids Establishing Therapy (FACET) International Study Group.

1 reference

12 December 2020

The interaction between salmeterol and beta 2-adrenoceptor agonists with higher efficacy on guinea-pig trachea and human bronchus in vitro

1 reference

12 December 2020

Impact of genetic polymorphisms of the beta2-adrenergic receptor on albuterol bronchodilator pharmacodynamics.

1 reference

12 December 2020

Sustained activation of a G protein-coupled receptor via "anchored" agonist binding. Molecular localization of the salmeterol exosite within the 2-adrenergic receptor

1 reference

12 December 2020

Pharmacokinetic/dynamic correlation of pulmonary and cardiac effects of fenoterol in asthmatic patients after different routes of administration.

1 reference

12 December 2020

Comparison of powder and aerosol formulations of salmeterol in the treatment of asthma

1 reference

12 December 2020

Pharmacokinetic and pharmacodynamic aspects of salmeterol therapy.

1 reference

12 December 2020

Identification of a key amino acid of the beta2-adrenergic receptor for high affinity binding of salmeterol

1 reference

12 December 2020

The characterisation of the major metabolite of salmeterol in the dog

1 reference

12 December 2020

Salmeterol, formoterol, and salbutamol in the isolated guinea pig trachea: differences in maximum relaxant effect and potency but not in functional antagonism

1 reference

12 December 2020

The beta-adrenoceptor

1 reference

12 December 2020

Cardiotoxic effects of salmeterol in comparison with salbutamol on the isolated perfused Langendorff-heart of the rat.

1 reference

12 December 2020

Determination of salmeterol in rat and dog plasma by high-performance liquid chromatography with fluorescence detection

1 reference

12 December 2020

Long-term drug treatment of asthma in children

1 reference

12 December 2020

The pharmacology of salmeterol

1 reference

12 December 2020

Metered dose inhaler salbutamol treatment of asthma in the ED: comparison of two doses with plasma levels

1 reference

12 December 2020

The contribution of the swallowed fraction of an inhaled dose of salmeterol to it systemic effects

1 reference

12 December 2020

Dose-response of inhaled drugs in asthma. An update

1 reference

12 December 2020

Coupled column chromatography in chiral separation of salmeterol

1 reference

12 December 2020

Rapid chiral high-performance liquid chromatographic assay for salmeterol and alpha-hydroxysalmeterol. Application to in vitro metabolism studies

1 reference

12 December 2020

Equilibrium and kinetic studies of the interactions of salmeterol with membrane bilayers

1 reference

12 December 2020

10.2165/00003088-200241010-00003

Identifiers

DOI

1 reference

Dimensions Publication ID

2 August 2017

0 references

1 reference